{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:37:16Z","timestamp":1782603436506,"version":"3.54.5"},"reference-count":75,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Ministry of Health, Labour and Welfare of Japan","award":["20FC1030"],"award-info":[{"award-number":["20FC1030"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Myelin phagocytosis by macrophages has been an essential feature of demyelinating diseases in the central and peripheral nervous systems, including Guillain\u2013Barr\u00e9 syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and multiple sclerosis (MS). The discovery of autoantibodies, including anti-ganglioside GM1 antibodies in the axonal form of GBS, anti-neurofascin 155 and anti-contactin 1 antibodies in typical and distal forms of CIDP, and anti-aquaporin 4 antibodies in neuromyelitis optica, contributed to the understanding of the disease process in a subpopulation of patients conventionally diagnosed with demyelinating diseases. However, patients with these antibodies are now considered to have independent disease entities, including acute motor axonal neuropathy, nodopathy or paranodopathy, and neuromyelitis optica spectrum disorder, because primary lesions in these diseases are distinct from those in conventional demyelinating diseases. Therefore, the mechanisms underlying demyelination caused by macrophages remain unclear. Electron microscopy studies revealed that macrophages destroy myelin as if they are the principal players in the demyelination process. Recent studies suggest that macrophages seem to select specific sites of myelinated fibers, including the nodes of Ranvier, paranodes, and internodes, for the initiation of demyelination in individual cases, indicating that specific components localized to these sites play an important role in the behavior of macrophages that initiate myelin phagocytosis. Along with the search for autoantibodies, the ultrastructural characterization of myelin phagocytosis by macrophages is a crucial step in understanding the pathophysiology of demyelinating diseases and for the future development of targeted therapies.<\/jats:p>","DOI":"10.3390\/cells10040844","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T10:34:39Z","timestamp":1617878079000},"page":"844","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Macrophages and Autoantibodies in Demyelinating Diseases"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4612-3183","authenticated-orcid":false,"given":"Haruki","family":"Koike","sequence":"first","affiliation":[{"name":"Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9453-9311","authenticated-orcid":false,"given":"Masahisa","family":"Katsuno","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,8]]},"reference":[{"key":"ref_1","first-page":"133","article-title":"Acute idiopathic polyneuritis. An electron microscope study","volume":"26","author":"Prineas","year":"1972","journal-title":"Lab. Investig."},{"key":"ref_2","first-page":"621","article-title":"Chronic inflammatory polyradiculoneuropathy","volume":"50","author":"Dyck","year":"1975","journal-title":"Mayo Clin Proc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1056\/NEJMra052130","article-title":"Multiple sclerosis\u2014The plaque and its pathogenesis","volume":"354","author":"Frohman","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.0000000000006625","article-title":"Ultrastructural mechanisms of macrophage-induced demyelination in CIDP","volume":"91","author":"Koike","year":"2018","journal-title":"Neurology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/jnnp-2019-322479","article-title":"Ultrastructural mechanisms of macrophage-induced demyelination in Guillain-Barr\u00e9 syndrome","volume":"91","author":"Koike","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0022-510X(76)90213-6","article-title":"Chronic relapsing polyneuritis","volume":"27","author":"Prineas","year":"1976","journal-title":"J. Neurol. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S1474-4422(13)70215-1","article-title":"Axonal Guillain-Barr\u00e9 syndrome: Concepts and controversies","volume":"12","author":"Kuwabara","year":"2013","journal-title":"Lancet Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/jnnp-2016-314895","article-title":"Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies","volume":"88","author":"Koike","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40120-020-00190-8","article-title":"Pathophysiology of Chronic Inflammatory Demyelinating Polyneuropathy: Insights into Classification and Therapeutic Strategy","volume":"9","author":"Koike","year":"2020","journal-title":"Neurol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/118.3.577","article-title":"Guillain-Barr\u00e9 syndrome in northern China: The spectrum of neuropathological changes in clinically defined cases","volume":"118","author":"Griffin","year":"1995","journal-title":"Brain"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions of Neuromyelitis optica: Distinction from multiple sclerosis","volume":"130","author":"Misu","year":"2007","journal-title":"Brain"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/brain\/109.6.1115","article-title":"An acute axonal form of Guillain-Barr\u00e9 polyneuropathy","volume":"109","author":"Feasby","year":"1986","journal-title":"Brain"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1212\/WNL.48.6.1694","article-title":"Axonal pathology in Japanese Guillain-Barr\u00e9 syndrome: A study of 15 autopsied cases","volume":"48","author":"Sobue","year":"1997","journal-title":"Neurology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.410400414","article-title":"Acute motor axonal neuropathy: An antibody-mediated attack on axolemma","volume":"40","author":"Hsieh","year":"1996","journal-title":"Ann. Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1523\/JNEUROSCI.4401-06.2007","article-title":"Anti-GM1 Antibodies Cause Complement-Mediated Disruption of Sodium Channel Clusters in Peripheral Motor Nerve Fibers","volume":"27","author":"Susuki","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/ene.13569","article-title":"Guillain-Barr\u00e9 syndrome in a local area in Japan, 2006\u20132015: An epidemiological and clinical study of 108 patients","volume":"25","author":"Matsui","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1212\/WNL.0000000000000566","article-title":"Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barre syndrome","volume":"83","author":"Sawai","year":"2014","journal-title":"Neurology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/jnnp-2016-314310","article-title":"Zika virus infection and Guillain-Barr\u00e9 syndrome: A review focused on clinical and electrophysiological subtypes","volume":"88","author":"Uncini","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"117272","DOI":"10.1016\/j.jns.2020.117272","article-title":"Guillain-Barr\u00e9 syndrome during the Zika virus outbreak in Northeast Brazil: An observational cohort study","volume":"420","author":"Leonhard","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.autrev.2016.03.020","article-title":"Zika virus and autoimmunity: From microcephaly to Guillain-Barr\u00e9 syndrome, and beyond","volume":"15","author":"Lucchese","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e12608","DOI":"10.1111\/aji.12608","article-title":"Minimal immune determinants connect Zika virus, human Cytomegalovirus, and Toxoplasma gondiito microcephaly-related human proteins","volume":"77","author":"Lucchese","year":"2017","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ana.25987","article-title":"SIESTA (Spanish Investigators in Emergency Situations Team) network. Incidence, clinical, risk factors and outcomes of Guillain-Barr\u00e9 in Covid-19","volume":"89","author":"Fragiel","year":"2021","journal-title":"Ann. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/brain\/awaa433","article-title":"Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barr\u00e9 syndrome","volume":"144","author":"Keddie","year":"2021","journal-title":"Brain"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"117263","DOI":"10.1016\/j.jns.2020.117263","article-title":"Guillain Barr\u00e9 Syndrome and its variants as a manifestation of COVID-19: A systematic review of case reports and case series","volume":"420","author":"Sriwastava","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.41.5.617","article-title":"Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)","volume":"41","author":"Cornblath","year":"1991","journal-title":"Neurology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society\u2014First revision","volume":"17","author":"Hadden","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/jnnp-2019-320741","article-title":"Clinicopathological characteristics of subtypes of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"90","author":"Ikeda","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.23794","article-title":"Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy","volume":"73","author":"Querol","year":"2013","journal-title":"Ann. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/jnnp-2014-309916","article-title":"Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies","volume":"86","author":"Doppler","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/acn3.248","article-title":"Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy","volume":"2","author":"Ogata","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jneuroim.2016.10.013","article-title":"IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: Clinical significance and diagnostic utility of a conventional assay","volume":"301","author":"Kadoya","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jnen\/nlz134","article-title":"Ultrastructural lesions of nodo-paranodopathies in peripheral neuropathies","volume":"79","author":"Vallat","year":"2020","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.nmd.2016.10.008","article-title":"Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies","volume":"27","author":"Vallat","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.2169\/internalmedicine.0455-17","article-title":"Restoration of a conduction block after the long-term treatment of CIDP with anti-neurofascin 155 antibodies: Follow-up of a case over 23 years","volume":"57","author":"Koike","year":"2018","journal-title":"Intern. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple Sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: The 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of multiple sclerosis","volume":"23","author":"Sospedra","year":"2005","journal-title":"Ann. Rev. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B-Cell Depletion with Rituximab in Relapsing\u2013Remitting Multiple Sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrneurol.2016.110","article-title":"Myeloid cells\u2014Targets of medication in multiple sclerosis","volume":"12","author":"Mishra","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s40478-018-0628-8","article-title":"The physiology of foamy phagocytes in multiple sclerosis","volume":"6","author":"Grajchen","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ana.410100205","article-title":"Multiple sclerosis: Capping of surface immunoglobulin G on macrophages engaged in myelin breakdown","volume":"10","author":"Prineas","year":"1981","journal-title":"Ann. Neurol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1474-4422(03)00308-9","article-title":"Multiple sclerosis in the Japanese population","volume":"2","author":"Kira","year":"2003","journal-title":"Lancet Neurol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"13052","DOI":"10.1073\/pnas.91.26.13052","article-title":"Molecular characterization of an aquaporin cDNA from brain: Candidate osmoreceptor and regulator of water balance","volume":"91","author":"Jung","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1002\/ana.410270717","article-title":"Macrophage responses in inflammatory demyelinating neuropathies","volume":"27","author":"Griffin","year":"1990","journal-title":"Ann. Neurol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1212\/WNL.44.6.1153","article-title":"Serum levels of soluble E-selectin (ELAM-1) in immune-mediated neuropathies","volume":"44","author":"Hartung","year":"1994","journal-title":"Neurology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/brain\/121.7.1257","article-title":"The role of the very late antigen-4 and its counterligand vascular cell adhesion molecule-1 in the pathogenesis of experimental autoimmune neuritis of the Lewis rat","volume":"121","author":"Enders","year":"1998","journal-title":"Brain"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/135245859800400110","article-title":"Soluble intercellular adhesion molecule-I (sICAM-I) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system","volume":"4","author":"Trojano","year":"1998","journal-title":"Mult. Scler."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1038\/s41467-018-07295-7","article-title":"Competitive repopulation of an empty microglial niche yields functionally distinct subsets of microglia-like cells","volume":"9","author":"Lund","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1007\/s00018-019-03431-8","article-title":"Behind the pathology of macrophage-associated demyelination in inflammatory neuropathies: Demyelinating Schwann cells","volume":"77","author":"Park","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/cen3.12442","article-title":"Deciphering the mechanism and spectrum of chronic inflammatory demyelinating polyneuropathy using morphology","volume":"9","author":"Koike","year":"2018","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/archneur.1969.00480150059008","article-title":"Landry-Guillain-Barr\u00e9 syndrome. A primary demyelinating disease","volume":"21","author":"Terry","year":"1969","journal-title":"Arch. Neurol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0022-510X(72)90001-9","article-title":"An ultrastructural study of an acute fatal case of the Guillain-Barr\u00e9 syndrome","volume":"15","author":"Carpenter","year":"1972","journal-title":"J. Neurol. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.410390512","article-title":"Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy","volume":"39","author":"Sheikh","year":"1996","journal-title":"Ann. Neurol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/(SICI)1097-4598(199707)20:7<846::AID-MUS9>3.0.CO;2-7","article-title":"Fulminant Guillain-Barr\u00e9 syndrome with universal inexcitability of peripheral nerves: A clinicopathological study","volume":"20","author":"Berciano","year":"1997","journal-title":"Muscle Nerve"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/1531-8249(199908)46:2<144::AID-ANA3>3.0.CO;2-K","article-title":"Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: A case for antigen-specific antibody mediation","volume":"46","author":"Raine","year":"1999","journal-title":"Ann. Neurol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Koike, H., and Katsuno, M. (2021). The role of macrophages in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy. Neurol. Clin. Neurosci, in press.","DOI":"10.1111\/ncn3.12496"},{"key":"ref_60","first-page":"127","article-title":"Mechanism of demyelination in experimental allergic neuritis. Electron microscopic studies","volume":"20","author":"Lampert","year":"1969","journal-title":"Lab. Investig."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF00685783","article-title":"Zur Feinstruktur der experimentell-allergischen Neuritis beim Kaninchen [Ultrastructure of experimental allergic neuritis in the rabbit]","volume":"14","year":"1970","journal-title":"Acta Neuropathol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00691436","article-title":"Electron microscopic studies on ordinary and hyperacute experimental allergic encephalomyelitis","volume":"9","author":"Lampert","year":"1967","journal-title":"Acta Neuropathol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0014-4886(67)90042-8","article-title":"Mechanism of demyelination in allergic encephalomyelitis of guinea pigs. An electron microscopic study","volume":"18","author":"Lampert","year":"1967","journal-title":"Exp. Neurol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0006-8993(79)91036-9","article-title":"Chronic relapsing experimental allergic encephalomyelitis: Morphological sequence of myelin degradation","volume":"169","author":"Lassmann","year":"1979","journal-title":"Brain Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0022-510X(92)90217-9","article-title":"Antibodies to acidic glycolipids in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"107","author":"Ilyas","year":"1992","journal-title":"J. Neurol. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/mus.880180407","article-title":"Anti-gal-C antibody in autoimmune neuropathies subsequent to mycoplasma infection","volume":"18","author":"Kusunoki","year":"1995","journal-title":"Muscle Nerve"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2011.08.016","article-title":"Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"239","author":"Kuwahara","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1529-8027.2012.00372.x","article-title":"Nodal proteins are target antigens in Guillain-Barr\u00e9 syndrome","volume":"17","author":"Devaux","year":"2012","journal-title":"J. Peripher. Nerv. Syst."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Koike, H., Ikeda, S., Fukami, Y., Nishi, R., Kawagashira, Y., Iijima, M., Nakamura, T., Kuwahara, M., Kusunoki, S., and Katsuno, M. (2020). Complement deposition and macrophage-induced demyelination in CIDP with anti-LM1 antibodies. J. Neurol. Sci., 408.","DOI":"10.1016\/j.jns.2019.116509"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/jnnp-2012-303440","article-title":"Clinical features of CIDP with LM1-associated antibodies","volume":"84","author":"Kuwahara","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","author":"Sato","year":"2014","journal-title":"Neurology"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Cobo-Calvo, \u00c1., d\u2019Indy, H., Ruiz, A., Collongues, N., Kremer, L., Durand-Dubief, F., Rollot, F., Casey, R., Vukusic, S., and De Seze, J. (2019). Frequency of myelin oligodendrocyte glycoprotein antibody in multiple sclerosis: A multicenter cross-sectional study. Neurol. Neuroimmunol. Neuroinflamm., 7.","DOI":"10.1212\/NXI.0000000000000649"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1474-4422(18)30114-5","article-title":"Safety and efficacy of eculizumab in Guillain-Barr\u00e9 syndrome: A multicentre, double-blind, randomised phase 2 trial","volume":"17","author":"Misawa","year":"2018","journal-title":"Lancet. Neurol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Shen, D., Chu, F., Lang, Y., Geng, Y., Zheng, X., Zhu, J., and Liu, K. (2018). Beneficial or Harmful Role of Macrophages in Guillain-Barr\u00e9 Syndrome and Experimental Autoimmune Neuritis. Mediat. Inflamm., 2018.","DOI":"10.1155\/2018\/4286364"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nn.3469","article-title":"M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination","volume":"16","author":"Miron","year":"2013","journal-title":"Nat. Neurosci."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/4\/844\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:34:27Z","timestamp":1760362467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/4\/844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,8]]},"references-count":75,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["cells10040844"],"URL":"https:\/\/doi.org\/10.3390\/cells10040844","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,8]]}}}